Europe Medical Foods Market Size To Reach $7.9 Billion By 2033

Europe Medical Foods Market Growth & Trends

The Europe medical foods market size is estimated to reach USD 7.9 billion by 2033, registering a CAGR of 2.8% from 2026 to 2033, according to a new report by Grand View Research, Inc. The ever-increasing burden of chronic diseases and the growing geriatric population across Europe are primary reasons for the market to flourish. In 2021, the oral route of administration accounted for the largest revenue share of 69.5%. Ease of use and high availability of medical foods in this form has contributed to the high revenue. The enteral route of administration is expected to register the fastest growth. This can be attributed to the growing geriatric population suffering from chronic diseases who are unable to consume food orally. The enteral route of administration seems to be the preferred way of administrating nutrients through medical foods to the specific needs of geriatric patients. 

In the product type, the powder formulations held the largest revenue share in 2025. Owing to the vast product portfolios available in this formulation this segment has grown to a large extent. Powder formulations include nutrient mixes, protein shakes, and infant feeding formulas. The highest growth was registered by the liquid formulations due to the diversification of product portfolios of the key players in the medical foods industry. Cancer had the largest revenue share in 2025 in the applications segment. Nutritional deficiency in cancer patients is a major concern and can be managed through proper nutrient management via medical foods and is a major factor in its growth. The fastest-growing sub-segment is diabetic neuropathy, high prevalence, and has been a key driver for its fast growth.

The largest sales channel for 2025 was direct-to-consumer, owing to the emerged as a significant channel within the market, providing opportunities for manufacturers to engage directly with consumers and tailor their offerings to meet specific health needs.

 Request a free sample copy or view report summary: Europe Medical Foods Market Report

Europe Medical Foods Market Report Highlights

• Based on route of administration, the oral segment led the market, accounting for 75.9% of total revenue in 2025, driven by increased preference for oral products, commercial viability, and supportive initiatives.

• Based on product, the powder segment accounted for the largest market revenue share of 35.3% in 2025. Owing to a strong preference for powdered formulations for their ease of consumption, manufacturers are developing product categories aligned with consumer preferences.

• Based on application, the cancer segment dominated the market with the largest share of 12.0% in 2025, driven by the rising prevalence of cancer and the high risk of disease-related malnutrition among patients undergoing cancer treatment.

• Based on modules, the protein module segment dominated the market with the largest revenue share of 12.8% in 2025. They are used in severe infections, trauma, burns, malnutrition, post-surgery recovery, and critically ill patients.

• Based on sales channel, the Direct-to-consumer (DTC) sales channel held the largest market share of 57.4% in 2025, providing manufacturers with opportunities to engage directly with consumers and tailor their offerings to specific health needs.

• The medical foods market in UK held a substantial share in 2025, driven by the growing geriatric population and rising risk of malnutrition among elderly individuals.

Europe Medical Foods Market Segmentation

Grand View Research has segmented the Europe Medical Foods market based on application, and region:

Europe Medical Foods Route of Administration Outlook (Revenue, USD Billion, 2021 - 2033)

• Oral

• Enteral

Europe Medical Foods Product Outlook (Revenue, USD Billion, 2021 - 2033)

• Pills

• Powder

• Liquid

• Others (semisolid, semiliquid)

Europe Medical Foods Application Outlook (Revenue, USD Billion, 2021 - 2033)

• Chronic Kidney Disease

• Minimal Hepatic Encephalopathy

• Chemotherapy Induced Diarrhoea

• Pathogen Related Infections

• Diabetic Neuropathy

• ADHD

• Depression

• Alzheimer's Disease

• Nutritional Deficiency

• Orphan Diseases

  • Tyrosinemia

  • Eosinophilic Esophagitis

  • Food Protein Module-induced enterocolitis syndrome (FPIES)

  • Phenylketonuria (PKU)

  • Maple syrup urine disease (MSUD)

  • Homocystinuria

  • Others (Urea Cycle Disorder (UCD), Glycogen Storage Disease (GSD), etc.)

• Wound Healing

• Chronic Diarrhea

• Constipation Relief

• Protein Booster

• Dysphagia

• Pain Management

• Parkinson's Disease

• Epilepsy

• Other Cancer related treatments

• Severe Protein Allergy

• Cancer

• Cachexia

• Other (debilitating conditions, COPD, etc.)

Europe Medical Foods Modules Outlook (Revenue, USD Billion, 2021 - 2033)

• Amino Acid Module

• Protein Module

• Vitamin & Mineral Modules

• Fatty Acid based Modules

• Carbohydrate Modules

• Fiber Modules

• Ketogenic Modules

• Peptide based Modules

• Hypoallergic Modules

• Others (Electrolyte Module, etc.)

Europe Medical Foods Sales Channel Outlook (Revenue, USD Billion, 2021 - 2033)

• DTC Sales Channel

  • Online Sales

  • Retail Sales

• Institutional Sales

  • Hospitals

  • Others (Long-term Care Facilities, etc.)

Europe Medical Foods Country Outlook (Revenue, USD Billion, 2021 - 2033)

• UK

• Germany

• Spain

• France

• Italy

• Denmark

• Sweden

• Norway

• Poland

• Netherlands

• Portugal

• Slovakia

• Finland

• Czech Republic

• Hungary

• Belgium

List of Key Players in the Europe Medical Foods Market

• Danone

• Nestlé

• Abbott

• Targeted Medical Pharma, Inc. (Physician Therapeutics, LLC, is a division of the company)

• Primus Pharmaceuticals, Inc.

• Fresenius Kabi AG

• Mead Johnson & Company, LLC